Barbara Kirschner to Disease Progression
This is a "connection" page, showing publications Barbara Kirschner has written about Disease Progression.
Connection Strength
0.194
-
Thalidomide use and outcomes in pediatric patients with Crohn disease refractory to infliximab and adalimumab. J Pediatr Gastroenterol Nutr. 2012 Jan; 54(1):28-33.
Score: 0.072
-
The Effect of Early-Life Environmental Exposures on Disease Phenotype and Clinical Course of Crohn's Disease in Children. Am J Gastroenterol. 2018 10; 113(10):1524-1529.
Score: 0.029
-
Malignancy and aneuploidy: prevention and early detection. Inflamm Bowel Dis. 1998 Aug; 4(3):216-20.
Score: 0.029
-
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study. Lancet. 2017 04 29; 389(10080):1710-1718.
Score: 0.026
-
Genetic and Metabolic Signals during Acute Enteric Bacterial Infection Alter the Microbiota and Drive Progression to Chronic Inflammatory Disease. Cell Host Microbe. 2016 Jan 13; 19(1):21-31.
Score: 0.024
-
Presentation and disease course in early- compared to later-onset pediatric Crohn's disease. Am J Gastroenterol. 2008 Aug; 103(8):2092-8.
Score: 0.014